Table 4. Distribution of C. neoformans isolates from clinical and environmental samples from Thailand and Japan in microsatellite complexes (MCs).
MCs | Chiang Mai, Thailand | Tokyo, Japan | |||
Clin. Isolatesn (%) | Env. Isolatesn (%) | Clin. Isolatesn (%) | Env. Isolatesn (%) | Total number of isolatesn (%) | |
MC1 | 0 | 0 | 0 | 0 | 0 |
MC2 | 12 (30) | 8 (13.8) | 11 (39.3) | 3 (33.3) | 34 (25.2) |
MC3 | 0 | 0 | 0 | 0 | 0 |
MC8 | 26 (65) | 45 (77.6) | 0 | 0 | 71 (52.6) |
MC12 | 0 | 3 (5.2) | 0 | 0 | 3 (2.2) |
MC15 | 0 | 1 (1.7) | 0 | 0 | 1 (0.7) |
MC16 | 0 | 0 | 16 (57.1) | 4 (44.4) | 20 (14.8) |
MC17 | 0 | 0 | 0 | 0 | 0 |
None MCs | 2 (5) | 1 (1.7) | 1 (3.6) | 2 (22.2) | 6 (4.5) |
Total | 40 | 58 | 28 | 9 | 135 |
The predominant MCs in each sample type in these countries are indicated in bold.